>>> SHP LN - Shire Sells Dermagraft Assets to Organogenesis; Sees Impairment. Sh SHP LN - Shire Sells Dermagraft Assets to Organogenesis; Sees Impairment. Shire to record a loss on disposal and associated impairment charges of ~$650m in 4Q